Your browser doesn't support javascript.
loading
Pathogenic BRCA1 mutations may be necessary but not sufficient for tissue genomic heterogeneity: Deep sequencing data from ovarian cancer patients.
Kotoula, Vassiliki; Lakis, Sotirios; Tikas, Ioannis; Giannoulatou, Eleni; Lazaridis, Georgios; Papadopoulou, Kyriaki; Manoussou, Kyriaki; Efstratiou, Ioannis; Papanikolaou, Alexios; Fostira, Florentia; Vlachos, Ioannis; Tarlatzis, Basil; Fountzilas, George.
Afiliação
  • Kotoula V; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki, Thessaloniki, Greece; Department of Pathology, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece. Electronic address: vkotoula@aut
  • Lakis S; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Tikas I; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki, Thessaloniki, Greece. Electronic address: ioantika@auth.gr.
  • Giannoulatou E; Victor Chang Cardiac Research Institute, Darlinghurst, NSW, Australia; University of New South Wales, Kensington, NSW, Australia.
  • Lazaridis G; Department of Medical Oncology, Papageorgiou Hospital, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece.
  • Papadopoulou K; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Manoussou K; Section of Biostatistics, Hellenic Cooperative Oncology Group, Athens, Greece. Electronic address: k_manoussou@hecog.ondsl.gr.
  • Efstratiou I; Department of Pathology, Papageorgiou Hospital, Thessaloniki, Greece.
  • Papanikolaou A; First Department of Obstetrics and Gynecology, Papageorgiou Hospital, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece. Electronic address: papalex@med.auth.gr.
  • Fostira F; Molecular Diagnostics Laboratory, INRASTES, National Center for Scientific Research NCSR Demokritos, Athens, Greece.
  • Vlachos I; Molecular Diagnostics Laboratory, INRASTES, National Center for Scientific Research NCSR Demokritos, Athens, Greece. Electronic address: ivlachos@lessr.eu.
  • Tarlatzis B; First Department of Obstetrics and Gynecology, Papageorgiou Hospital, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece.
  • Fountzilas G; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki, Thessaloniki, Greece; Aristotle University of Thessaloniki, Thessaloniki, Greece. Electronic address: fountzil@auth.gr.
Gynecol Oncol ; 152(2): 375-386, 2019 02.
Article em En | MEDLINE | ID: mdl-30446274
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mutação em Linhagem Germinativa / Proteína BRCA1 / Carcinoma Epitelial do Ovário Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mutação em Linhagem Germinativa / Proteína BRCA1 / Carcinoma Epitelial do Ovário Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article